T1	PROC 0 34	Terapia de deprivación androgénica
T2	Duration 35 60	de corta ó larga duración
T3	PROC 80 103	radioterapia de rescate
T4	LIVB 107 116	pacientes
#1	AnnotatorNotes T4	C0030705; Patients; Patient or Disabled Group
T5	DISO 121 139	cáncer de próstata
#2	AnnotatorNotes T5	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T6	DISO 144 163	recidiva bioquímica
#3	AnnotatorNotes T6	C2825055; Recurrence (disease attribute); Pathologic Function
T7	PROC 169 176	cirugía
#4	AnnotatorNotes T7	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T8	PROC 181 236	ensayo fase III aleatorizado, controlado, multicéntrico
T9	PROC 261 295	Terapia de deprivación androgénica
T10	Duration 296 321	de corta ó larga duración
T11	PROC 341 364	radioterapia de rescate
T12	LIVB 368 377	pacientes
#5	AnnotatorNotes T12	C0030705; Patients; Patient or Disabled Group
T13	DISO 382 400	cáncer de próstata
T14	DISO 405 424	recidiva bioquímica
#6	AnnotatorNotes T14	C2825055; Recurrence (disease attribute); Pathologic Function
T15	PROC 430 437	cirugía
#7	AnnotatorNotes T15	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T16	DISO 459 477	cáncer de próstata
#8	AnnotatorNotes T16	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T17	DISO 506 524	Cáncer de próstata
#9	AnnotatorNotes T17	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T18	PROC 536 552	histológicamente
T19	PROC 566 588	prostatectomía radical
#10	AnnotatorNotes T19	C0194810; Radical prostatectomy; Therapeutic or Preventive Procedure
T20	PROC 590 592	PR
#11	AnnotatorNotes T20	C0337380; Endoscopic retrograde pancreatography; Diagnostic Procedure
T21	LIVB 614 623	pacientes
#12	AnnotatorNotes T21	C0030705; Patients; Patient or Disabled Group
T22	Neg_cue 624 627	sin
T23	PROC 628 643	linfadenectomía
#13	AnnotatorNotes T23	C0024203; Lymph node excision; Therapeutic or Preventive Procedure
T24	Negated 628 643	linfadenectomía
T25	DISO 648 667	Recidiva bioquímica
#14	AnnotatorNotes T25	C2825055; Recurrence (disease attribute); Pathologic Function
T26	PROC 672 675	PSA
#15	AnnotatorNotes T26	C0201544; Prostate specific antigen measurement; Laboratory Procedure
T27	PROC 681 695	prostatectomía
#16	AnnotatorNotes T27	C0033573; Prostatectomy; Therapeutic or Preventive Procedure
T28	Duration 777 788	≥ 2 semanas
T29	PROC 793 805	nivel de PSA
T30	PROC 850 857	Gleason
T31	PROC 903 906	PSA
#17	AnnotatorNotes T31	C0201544; Prostate specific antigen measurement; Laboratory Procedure
T32	PROC 928 940	nivel de PSA
T33	PROC 970 990	estudio de extensión
T34	PROC 1001 1027	pruebas de imagen avanzada
T35	PROC 1033 1036	PET
#18	AnnotatorNotes T35	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T36	PROC 1044 1050	Colina
T37	PROC 1082 1085	TAC
#19	AnnotatorNotes T37	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T38	PROC 1088 1104	gammagrafía ósea
#20	AnnotatorNotes T38	C0203668; Radioisotope scan of bone; Diagnostic Procedure | C3889015; Bone scintigraphy; Diagnostic Procedure
T39	PROC 1113 1125	nivel de PSA
T40	Neg_cue 1152 1154	no
T41	PROC 1171 1185	estadificación
T42	Negated 1171 1185	estadificación
T43	DISO 1205 1215	metástasis
#21	AnnotatorNotes T43	C0027627; Neoplasm Metastasis; Neoplastic Process | C2939419; Secondary Neoplasm; Neoplastic Process
T44	LIVB 1267 1276	Pacientes
#22	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	PROC 1421 1430	protocolo
#23	AnnotatorNotes T45	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T46	PROC 1444 1465	Nivel de testosterona
#24	AnnotatorNotes T46	C0523912; Testosterone measurement; Laboratory Procedure
T47	LIVB 1523 1532	pacientes
#25	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	Duration 1566 1574	> 5 años
T49	PROC 1578 1602	Consentimiento informado
#26	AnnotatorNotes T49	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T50	DISO 1654 1668	enfermedad pN1
T51	ANAT 1675 1693	muestra quirúrgica
T52	DISO 1719 1742	enfermedad macroscópica
T53	PROC 1771 1783	nivel de PSA
T54	PROC 1787 1798	diagnóstico
#27	AnnotatorNotes T54	C0011900; Diagnosis; Diagnostic Procedure
T55	PROC 1840 1857	pruebas de imagen
T56	PROC 1859 1862	TAC
#28	AnnotatorNotes T56	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T57	PROC 1865 1881	gammagrafía ósea
#29	AnnotatorNotes T57	C0203668; Radioisotope scan of bone; Diagnostic Procedure | C3889015; Bone scintigraphy; Diagnostic Procedure
T58	PROC 1886 1889	PET
#30	AnnotatorNotes T58	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T59	PROC 1890 1892	TC
#31	AnnotatorNotes T59	C0018823; Heart Transplantation; Therapeutic or Preventive Procedure | C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T60	PROC 1894 1901	RM Body
T61	PROC 1907 1910	PSA
#32	AnnotatorNotes T61	C0201544; Prostate specific antigen measurement; Laboratory Procedure
T62	PROC 1979 2001	prostatectomía radical
#33	AnnotatorNotes T62	C0194810; Radical prostatectomy; Therapeutic or Preventive Procedure
T63	PROC 2006 2016	RT pélvica
T64	PROC 2067 2078	irradiación
T65	Contraindicated 2067 2078	irradiación
T66	PROC 2082 2108	Tratamiento activo con TDA
#34	AnnotatorNotes T66	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T67	CHEM 2111 2139	fármacos moduladores del PSA
T68	CHEM 2154 2165	finasterida
#35	AnnotatorNotes T68	C0060389; finasteride; Hormone · Organic Chemical · Pharmacologic Substance
T69	CHEM 2167 2178	dutasterida
#36	AnnotatorNotes T69	C0754659; dutasteride; Organic Chemical · Pharmacologic Substance
T70	CHEM 2180 2190	esteroides
#37	AnnotatorNotes T70	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T71	Dose 2194 2205	dosis altas
T72	Neg_cue 2210 2212	No
T73	PHYS 2219 2229	comprender
T74	Negated 2219 2229	comprender
T75	PROC 2233 2257	protocolo de tratamiento
#38	AnnotatorNotes T75	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T76	Neg_cue 2258 2260	ni
T77	PROC 2271 2295	consentimiento informado
#39	AnnotatorNotes T77	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T78	Negated 2271 2295	consentimiento informado
T79	PROC 1746 1763	pruebas de imagen
T80	PROC 1037 1041	PSMA
T81	PROC 1062 1081	imagen convencional
T82	PROC 1537 1541	ECOG
T83	Result_or_Value 721 734	≥ 0,2 ng / ml
T84	Quantifier_or_Qualifier 740 752	al menos una
T85	Result_or_Value 858 862	8-10
T86	Observation 864 868	pT3b
T87	Observation 871 873	R1
T88	CONC 889 898	inclusión
T89	Result_or_Value 907 920	≥0,15 ng / ml
T90	Result_or_Value 943 956	> 0,4 ng / ml
T91	Quantifier_or_Qualifier 1019 1027	avanzada
T92	Result_or_Value 1132 1150	0,15 y 0,4 ng / ml
T93	CONC 1240 1249	inclusión
T94	Observation 1280 1297	riesgo intermedio
T95	Observation 1300 1311	alto riesgo
T96	Result_or_Value 1466 1489	por encima de 150 ng/dl
T97	CONC 1537 1541	ECOG
T98	Result_or_Value 1542 1545	0-1
T99	CONC 1549 1566	Esperanza de vida
T100	Result_or_Value 1801 1814	> 0,4 ng / ml
T101	Result_or_Value 1911 1929	<0,2 o <0,15 ng/mL
T102	Observation 1952 1956	pT3b
T103	Observation 1959 1961	R1
T104	Quantifier_or_Qualifier 2094 2100	activo
T105	Quantifier_or_Qualifier 2132 2139	del PSA
T106	Patient 107 116	pacientes
T107	Patient 368 377	pacientes
T108	Patient 614 623	pacientes
T109	Patient 1267 1276	Pacientes
T110	Patient 1523 1532	pacientes
T111	History_of 2006 2016	RT pélvica
